NUSTEO (Q4111078)
Jump to navigation
Jump to search
Project Q4111078 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NUSTEO |
Project Q4111078 in Italy |
Statements
2,582,331.73 Euro
0 references
3,984,282.0 Euro
0 references
64.81 percent
0 references
MEDIVIS SRL
0 references
37°30'8.50"N, 15°5'14.53"E
0 references
PROGETTO N. 08CT2120090065 - CAPOFILA MEDIVISSRL*CORSO ITALIA, 171*STUDIO E SVILUPPO DI 2NUOVE FORMULAZIONI FARMACOLOGICHE NELSETTORE OFTALMICO PER LA PREVENZIONE E LACURA DELLE INFEZIONI BATTERICHE, VIRALI EMICROBICHE CHE, SE NON TRATTATEADEGUATAMENTE ED IN TEMPO, POSSONOCOMPORTARE LA PERDITA DELLA VISTA. (Italian)
0 references
PROJECT NO 08CT2120090065 — LEADER MEDIVISSRL*CORSO ITALIA, 171*STUDY AND DEVELOPMENT OF 2NEW PHARMACOLOGICAL FORMULATIONS IN THE OPHTHALMIC SECTOR FOR THE PREVENTION AND TREATMENT OF BACTERIAL, VIRAL INFECTIONS EMICROBICHE WHICH, IF NOT TREATEDDEGUATALY AND IN TIME, CAN LEAD TO LOSS OF VISION. (English)
28 January 2022
0 references
PROJET NO 08CT2120090065 — LEADER MEDIVISSRL*CORSO ITALIA, 171*ÉTUDE ET DÉVELOPPEMENT DE 2NOW FORMULATIONS PHARMACOLOGIQUES DANS LE SECTEUR OPHTALMIQUE POUR LA PRÉVENTION ET LE TRAITEMENT DES INFECTIONS BACTÉRIENNES VIRALES EMICROBICHE QUI, SI CE N’EST TREATEDDEGUATALY ET DANS LE TEMPS, PEUVENT ENTRAÎNER UNE PERTE DE VISION. (French)
28 January 2022
0 references
PROJEKT Nr. 08CT2120090065 – LEADER MEDIVISSRL*CORSO ITALIA, 171*STUDIE UND ENTWICKLUNG VON 2NEW PHARMAKOLOGISCHEN FORMULIERUNGEN IM OPHTHALMISCHEN BEREICH ZUR PRÄVENTION UND BEHANDLUNG VON BAKTERIELLEN, VIRALEN INFEKTIONEN EMICROBICHE, DIE, WENN NICHT TREATEDDEGUATALY UND RECHTZEITIG, ZU SEHVERLUST FÜHREN KÖNNEN. (German)
28 January 2022
0 references
PROJECT NR. 08CT2120090065 — LEIDER MEDIVISSRL*CORSO ITALIA, 171*STUDIE EN ONTWIKKELING VAN 2NIEUWE FARMACOLOGISCHE FORMULERINGEN IN DE OOGHEELKUNDE VOOR DE PREVENTIE EN BEHANDELING VAN BACTERIËLE, VIRALE INFECTIES EMICROBICHE DIE, ZO NIET TREATEDDEGUATALY EN OP TIJD, KUNNEN LEIDEN TOT VERLIES VAN GEZICHTSVERMOGEN. (Dutch)
29 January 2022
0 references
PROYECTO N.º 08CT2120090065 — LÍDER MEDIVISSRL*CORSO ITALIA, 171*ESTUDIO Y DESARROLLO DE FORMULACIONES FARMACOLÓGICAS 2NEW EN EL SECTOR OFTÁLMICO PARA LA PREVENCIÓN Y EL TRATAMIENTO DE INFECCIONES BACTERIANAS, VIRALES EMICROBICHE QUE, SI NO TREATEDDEGUATALIA Y A TIEMPO, PUEDEN CONDUCIR A LA PÉRDIDA DE VISIÓN. (Spanish)
30 January 2022
0 references
CATANIA
0 references